All posts by Celdara Medical

Celdara Medical Awarded SBIR Fast-Track Funding for Development of Cell Therapy for Amyotrophic Lateral Sclerosis

Lebanon, NH: The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) has awarded Celdara Medical a Fast-Track Small Business Innovation Research (SBIR) grant to fund the development of engineered regulatory T cells (Tregs) therapy for Amyotrophic Lateral Sclerosis (ALS). ALS is a debilitating […]

Continue Reading

Call for Applications: Celdara Medical High Potential Entrepreneurs’ Fellowship 2023-24

Fellowship Call for Applications

Celdara Medical seeks outstanding scientists with an interest in translational research and biotechnology for a paid Fellowship ($15/hour – remote optional). Prior Fellows have jumpstarted their careers in Venture Capital, Management Consulting, Technology Transfer, R&D, Medical Writing, and Business Development.​    Program Description​  1-year experiential learning to gain real-world experience in biotechnology​  Develop executive skills including […]

Continue Reading

Celdara Medical Awarded Phase II SBIR Funding to Develop Therapeutics for Pandemic-Potential Influenza Strains

Program NoAs Template 2023

Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Innovation Research (SBIR) Fast-Track grant to Celdara Medical. This award supports the ongoing development of CM-IAV1, a promising therapeutic antibody designed to treat high-priority influenzas that […]

Continue Reading

Celdara Medical and University of Vermont Funded to Develop Therapeutic Antibodies for Hantavirus Cardiopulmonary Syndrome

Employee Highlight (3)

Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Technology Transfer (STTR) grant to fund the ongoing development of therapeutic antibodies for the treatment of Hantavirus Cardiopulmonary Syndrome (HCPS). The funding will support the ongoing […]

Continue Reading


Position Description Celdara Medical, LLC (CM) is building a portfolio of early-stage medical companies in collaboration with leading academicians. Each of these is at a different stage of development with a different development path. Celdara aims to bring these products to market with urgency. Our Mission is to give hope […]

Continue Reading

Celdara Announces DRIVEN Fund Awardees

driven thumb 1

Celdara Medical, LLC today announced the awarding of six DRIVEN Accelerator Hub grants to outstanding researchers and innovators in the Northeast region. In this most recent round of funding, two Acceleration Awards (up to $50,000 per early-stage company) were awarded to Olfax Medical (Vermont) and ResusciTech (Rhode Island) and 4 Ignition Awards (up to $25,000 per faculty innovator) were awarded to Andre Khalil, PhD (University of Maine), Gian Ignacio, MD Candidate (Brown), Michael Cole, PhD (Dartmouth), and Yina Huang, PhD (Dartmouth).

Continue Reading

Celdara Medical Names Entrepreneur Fellows

Fellowship Announcement 2021 Final

Celdara Medical, LLC today announced the selection of five outstanding researchers as the recipients of the 2021 Celdara Medical High-Potential Entrepreneurs’ Fellowships (CHEF). The program provides a part-time, year-long experiential learning opportunity at Celdara to senior graduate students and post-doctoral researchers. Fellows receive an opportunity to hone their executive skills […]

Continue Reading

Enquire now

Give us a call or fill in the form below and we'll contact you. We endeavor to answer all inquiries within 24 hours on business days.